BridgeBio Pharma (BBIO) Enterprise Value (2018 - 2026)
BridgeBio Pharma (BBIO) reported Enterprise Value of -$929.7 million for Q1 2026, down 75.21% on a YoY basis from -$3.8 billion in Q1 2025, and down 61.17% sequentially from -$576.9 million in Q4 2025.
BridgeBio Pharma (BBIO) Enterprise Value (2018 - 2026) Analysis & Trends
BridgeBio Pharma (BBIO) has 9 years of Enterprise Value data on file, last reported at -$929.7 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 75.21% year-over-year to -$929.7 million; the trailing twelve-month figure through Mar 2026 stood at -$929.7 million (down 75.21% YoY), and the FY2025 full-year result was -$576.9 million, down 65.0% from the prior year.
- Enterprise Value retreated to -$929.7 million in Q1 2026, from -$576.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$255.4 million in Q3 2024 to a low of -$929.7 million in Q1 2026.
- A 5-year average of -$477.0 million and a median of -$463.2 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value surged 55.44% in 2022 and plunged 75.21% in 2026, its largest moves.
- Tracing BBIO's Enterprise Value over 5 years: stood at -$403.3 million in 2022, then grew by 5.45% to -$381.3 million in 2023, then climbed by 8.32% to -$349.6 million in 2024, then tumbled by 65.0% to -$576.9 million in 2025, then slumped by 61.17% to -$929.7 million in 2026.
- Business Quant data shows BBIO's Enterprise Value at -$929.7 million in Q1 2026, -$576.9 million in Q4 2025, and -$276.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn | -929.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -929.75 Mn |
| Dec 31, 2025 | -576.88 Mn |
| Sep 30, 2025 | -276.02 Mn |
| Jun 30, 2025 | -747.01 Mn |
| Mar 31, 2025 | -530.64 Mn |
| Dec 31, 2024 | -349.63 Mn |
| Sep 30, 2024 | -255.44 Mn |
| Jun 30, 2024 | -536.31 Mn |
| Mar 31, 2024 | -463.21 Mn |
| Dec 31, 2023 | -381.34 Mn |
| Sep 30, 2023 | -492.81 Mn |
| Jun 30, 2023 | -321.26 Mn |
| Mar 31, 2023 | -444.92 Mn |
| Dec 31, 2022 | -403.34 Mn |
| Sep 30, 2022 | -506.47 Mn |
| Jun 30, 2022 | -485.22 Mn |
| Mar 31, 2022 | -408.99 Mn |
| Dec 31, 2021 | -390.54 Mn |
| Sep 30, 2021 | -595.06 Mn |
| Jun 30, 2021 | -835.80 Mn |